Cara Therapeutics Inc (NASDAQ:CARA)

12.42
BATS BZX Real-Time Price
As of 12:48pm ET
 -0.49 / -3.80%
Today’s Change
11.22
Today|||52-Week Range
29.65
-17.91%
Year-to-Date

Stock Price Forecast

The 8 analysts offering 12-month price forecasts for Cara Therapeutics Inc have a median target of 27.00, with a high estimate of 35.00 and a low estimate of 17.00. The median estimate represents a +117.39% increase from the last price of 12.42.

Analyst Recommendations

The current consensus among 8 polled investment analysts is to Buy stock in Cara Therapeutics Inc. This rating has held steady since October, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.52
Sales
$1.5M
Reporting Date
Mar 10

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -2,485.72%
 
 
 
 
 
 
Growthannually -1,030.16%
 
 
 
 
 
 

Sales

Growthquarterly -92.81%
 
 
 
 
 
 
Growthannually -82.73%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.